Quantcast
0
0
The efficacy of FDA-approved drug inhibiting the ‘cap snatching’ endonuclease of RdRP polymerase is undermined by the emergence of resistant influenza virus strains
$
X
Sharing:
Title:
URL:
Copy Share URL